Healthcare Private Equity for the European Midmarket
Healthcare Private Equity for the European Midmarket
Atlas Health is a Private Equity fund which was established to invest in European Healthcare companies to improve patient outcomes globally.
We have 30 years' experience investing in European midmarket Healthcare. We focus on Medtech, niche Pharma / OTC, and Animal Health - areas where we have deep industry expertise and have been involved in tremendous growth stories across Europe.
We have found that - through combining ambition, dedication to our core sub-sectors and true partnership with management teams - we can outperform to the benefit of all of our stakeholders.
We aim to invest £25m-100m of equity in each company, and recycle the profits from our investments into a philanthropic foundation. This allows us to continue the cycle of improving patient outcomes.
We believe that our work has a direct, tangible and positive impact on patient outcomes.
We like to back niche businesses with clear roles in the human and animal Healthcare ecosystems, staffed by mission-driven teams.
We believe midmarket companies are nimble enough to adapt rapidly and reimagine industries on a more sustainable model.
As active investors we play a part in helping shape how the Healthcare industry evolves.
We are passionate about the Healthcare sector and delivering transformational growth.
We relish the challenge that goes with tackling complex transactions and developing and executing on ambitious business plans.
Our aim is to build our Philanthropic Foundation into a major force for good, allowing us to continue to improve society well after the end of our investment cycles.
Our founders have spent 30 years operating and investing in, Medtech, Pharma, and Animal Health, including the services and software companies supporting those segments.
We stick to what we know so we can deliver for our investors and the teams we work with.
Over time our networks in industry have grown to be substantial. This gives us access to differentiated opportunities and insights.
We have found that developing ambitious value creation plans from the start of an investment leads to outperformance.
We embrace complexity, and transformational investment in the businesses we back.
We are prepared to take a hands-on approach to implementing our value creation model via R&D, in-licensing, M&A, commercial and operational excellence and international expansion.
We work with management teams and non-executives whom we like and respect, and who are excited to work with us.
We work with companies who share our aim of improving patient outcomes and giving back to both society and the environment.
We act with integrity - we believe our reputation is everything and are happy to introduce potential partners to those we have worked with before.
Medtech, Niche Pharma / OTC, and Animal Health.
Businesses which are industry leaders in their respective niches, and benefiting from market tailwinds and underlying macroeconomic and demographic trends.
Management teams who are committed to the future of their business, either as part of a transition or as future leaders, as opposed to looking for pure value maximisation.
Typically using one of the 5 key routes where we believe we can accelerate value creation. We look to build long-term growth businesses rather than implement short term jumps in revenues or profits.
Across the length of our investment period.
We embrace starting with small investments where we can deploy further capital during our investment period.
A willingness to focus the Board-level ESG agenda on improving patient outcomes by limiting our impact on the environment.
To our Why, to Healthcare, and to everything we work on. We combine passion with determination.
We expect to be treated as we treat others. To get great partners, we have to be great partners.
We set ourselves high standards of performance and behaviour. We believe that if we set high standards day in, day out we will outperform over the long term.
We like to ask questions and value it when others do the same. We would rather be smart than look smart and believe the first step to this is in acknowledging what we don't know.
To deliver great outcomes for patients and build great businesses. Outperforming ourselves every time.
18-20 Kew Rd, Richmond TW9 2NA, UK